Advanced search
Publication Cover
Expert Opinion on Drug Delivery Volume 2, 2005 - Issue 1
Submit an article Journal homepage
746
Views
133
CrossRef citations to date
0
Altmetric
Review

Solid lipid microparticles: formulation, preparation, characterisation, drug release and applications

Séverine Jaspart University of Liège, Laboratory of Pharmaceutical Technology, Tour 4, étage 2, Avenue de l’hôpital 1, 4000 Liège, Belgium. [email protected]
,
Géraldine Piel University of Liège, Laboratory of Pharmaceutical Technology, Tour 4, étage 2, Avenue de l’hôpital 1, 4000 Liège, Belgium. [email protected]
,
Luc Delattre University of Liège, Laboratory of Pharmaceutical Technology, Tour 4, étage 2, Avenue de l’hôpital 1, 4000 Liège, Belgium. [email protected]
&
Brigitte Evrard University of Liège, Laboratory of Pharmaceutical Technology, Tour 4, étage 2, Avenue de l’hôpital 1, 4000 Liège, Belgium. [email protected]
Pages 75-87 | Published online: 22 Apr 2005

Bibliography

  • MEHNERT W, MADER K: Solid lipid nanoparticles: production, characterization and applications. Adv. Drug Deliv. Rev. (2001) 47:165–196.
  • •• Excellent review of SLNs.
  • ZENG XM, MARTIN GP, MARRIOTT C: The controlled delivery of drugs to the lung. Int. J. Pharm. (1995):149–164.
  • BARRATT GM: Therapeutic applications of colloidal drug carriers. Pharm. Sci. Technol Today (2000) 3(5):163–171.
  • SHARMA A, SHARMA US: Liposomes in drug delivery: Progress and limitations. Int. J. Pharm. (1997) 154(2):123–140.
  • MANOSROI A, KONGKANERAMIT L, MANOSROI J: Stability and transdermal absorption of topical amphotericin B liposome formulations. Int. j Pharm. (2004) 270(1-2):279–286.
  • BRANNON-PEPPAS L: Recent advances on the use of biodegradable microparticles and nanoparticles in controlled drug delivery. Int. J. Pharm. (1995) 116(1):1–9.
  • RAW KUMAR MNV: Nano and microparticles as controlled drug delivery devices. J. Pharm. Pharm. Sci. (2000) 3(2):234–258.
  • SOPPIMATH KS, AMINABHAVI TM, KULKARNI AR et al.: Biodegradable polymeric nanoparticles as drug delivery devices. J. Control. Release (2001) 70(1-2):1–20.
  • ALLEMAN E, GURNY R, DOELKER E: Drug-loaded nanoparticles - preparation methods and drug targeting issues. Eur. Pharm. Biopharm. (1993) 39(5):173–191.
  • REITHMEIER H, HERRMANN J, GOPFERICH A: Development and characterization of lipid microparticles as a drug carrier for somatostatin. Int. j Pharm. (2001) 218:133–143.
  • •• Article of considerable interest.
  • GUPTA PK, ADJEI AL: Modulated-release aerosol. In: Inhalation delivery of therapeutic peptides and proteins. Lung
  • DEL VALLE EMM: Cyclodextrins and their uses: a review. Process Biochemistry (2004) 39(9):1033–1046.
  • DUCHENE D, WOUESSIDJEWE D, PONCHEL G: Cyclodextrins and carrier systems. J. Control. Release (1999) 62(1–
  • HU FQ, YUAN H, ZHANG HH et al.: Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and
  • MULLER RH, MADER K, GOHLA S: Solid lipid nanoparticles (SLN) for controlled drug delivery- a review of the
  • SCHWARZ C, MEHNERT W: Solid lipidnanoparticles (SLN) for controlled drug delivery; drug incorporation and physicochemical characterization. J. Microencapsul. (1999) 16(2):205–213.
  • VENKATESWARLU V, MANJUNATH K: Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles. J. Control. Release (2004) 95:627–638.
  • ZUR MUHLEN A. SCHWARZ C, MEHNERT W: Solid lipid nanoparticles (SLN) for controlled drug delivery- Drug release and release mechanism. Eur. J. Pharm. Biopharm. (1998) 45:149–155.
  • HOU D, XIE C, HUANG K et al.: The production and characteristics of solid lipid nanoparticles (SLNs). Biomateriais (2003) 24(10):1781–1785.
  • SAVOLAINEN M, HERDER J, KHOO C et al.: Evaluation of polar lipid-hydrophilic polymer microparticles. Int. j Pharm. (2003) 262(1-2):47–62.
  • • Article of interest.
  • PASSERINI N, PERISSUTTI B, ALBERTINI B et al.: Controlled release of verapamil hydrochloride from waxy microparticles prepared by spray congealing. J. Control. Release (2003) 88(2):263–275.
  • • Article of interest.
  • AKIYAMA Y, YOSHIOKA M, HORIBE H et al.: Novel oral controlled-release microspheres using polyglycerol esters of fatty acids. J. Control. Release (1993) 26(1):1–10.
  • RODRIGUEZ L, PASSERINI N, CAVALLARI C et al.: Description and preliminary evaluation of a new ultrasonic atomizer for spray-congealing processes. Int. Pharm. (1999) 183(2):133–143.
  • DEL CURTO MD, CHICCO D, D'ANTONIO M et al.: Lipid microparticles as sustained release system for a GnRH antagonist (Amide)." Control. Release (2003) 89:297–310.
  • • Article of interest.
  • FREDERIKSEN HK, KRISTENSEN HG, PEDERSEN M: Solid lipid microparticle formulations of the pyrethroid gamma-cyhalothrin- incompatibility of the lipid and the pyrethroid and biological properties of the formulations. J. Control. Release (2003) 86:243–252.
  • DEMIREL M, YAZAN Y, MULLER RH et al.: Formulation and in vitro-in vivo evaluation of piribedil solid lipid micro- and nanoparticles. j Microencapsa. (2001) 18(3):359–371.
  • SANNA V, KIRSCHVINK N, GUSTIN P et al.: Preparation and in vivo toxicity study of solid lipid microparticles as carrier for pulmonary administration. AAPS PharmSci Tech (2004) 5(2):Article 27.
  • ELDEM T, SPEISER P, HINCAL A: Optimization of spray-dried and congealed lipid micropellets and characterization of their surface morphology by scanning electron microscopy. Pharm. Res. (1991) 8(1):47–54.
  • BODMEIER R, WANG J, BHAGWATWAR H: Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. I. Oil-in-water technique for water-insoluble drugs. J. Microencapsul. (1992) 9(1):89–98.
  • BODMEIER R, WANG J, BHAGWATWAR H: Process and formulation variables in the preparation of wax microparticles by a melt dispersion technique. II. W/O/W multiple emulsion technique for water-soluble drugs. J. Microencapsul. (1992) 9(1):99–107.
  • REITHMEIER H, HERRMANN J, GOPFERICH A: Lipid microparticles as parenteral controlled release device for peptides. J. Control. Release (2001) 73:339–350.
  • •Article of interest.
  • ERNI C, SUARD C, FREITAS S et al.: Evaluation of cationic sold lipid microparticles as synthetic carriers for the targeted delivery of macromolecules to phagocytic antigen-presenting cells. Biomaterials (2004) 23:4667–4676.
  • REITHMEIER H, GOPFERICH A, HERRMANN J: Preparation and characterization of lipid microparticles containing insulin. Proceedings of the 2nd World Meeting APGI/APV Paris, France (1998) 1079.
  • MASTERS DB, DOMB AJ: Liposphere local anesthetic timed-release for perineural site application. Pharm. Res. (1998) 15(7):1038–1045.
  • BENITA S, ZOUAI O, BENOIT JP: 5 - Fluorouracil: carnauba wax microspheres for chemoembloization: An in vitro evaluation. J. Pharm. Sci. US (1986) 75(9):847–851.
  • PASSERINI N, PERISSUTI B, MONEGHINI M et al.: Characterization of carbamazepine-Gelucire 50/13 microparticles prepared by a spray-congealing process using ultrasounds. J. Pharm. Sci-US (2002) 91(3):699–707.
  • • Article of interest.
  • YENER G, INCEGUL T, YENER N: Importance of using solid lipid microspheres as carriers for UV filters on the example octyl methoxy cinnamate. Int. Pharm. (2003) 258:203–207.
  • GIANNOLA LI, DI STEFANO V, DE CARO V: -White beeswax microspheres: a comparative in vitro evaluation of cumulative release of the anticancer agents fluorouracil and ftorafur. Pharmazie (1993) 48(2):123–126.
  • BRASSEUR S, AMIGHI K, MOES AJ: Evaluation of solid lipid microparticles for controlled delivery to the pulmonary tract. Proceedings of the 9th Forum of Pharmaceutical Sciences. Spa, Belgium (2000) 11.
  • MALAMATARIS S, PANAGOPOULOU A, HATZIPANTOU P: Controlled release from glycerol palmito-stearate matrices prepared by dry-heat granulation and compression at elevated temperature. Drug. Dev. Ind. Pharm. (1991) 17:1765–1777.
  • SAVOLAINEN M, KHOO C, GLAD H et al.: Evaluation of controlled-release polar lipid microparticles. Int. J. Pharm. (2002) 244:151–161.
  • CORTESI R, ESPOSITO E, LUCA G et al.: Production of lipospheres as carriers for bioactive compounds. Biomaterials (2002) 23(10:2283–2294.
  • MULLER RH, MEHNERT W, LUCKS JS et al.: Solid lipid nanoparticles (SLN) - an alternative colloidal carrier system for controlled drug delivery. Eur. j Pharm. Biopharm. (1995) 41(1):62–69.
  • SUGIURA S, NAKAJIMA M, TONG J et al.: Preparation of monodispersed solid lipid microspheres using a microchannel emulsification technique. J. Colloid Intof Sri. (2000) 227:95–103.
  • KAWAKATSU T, TRAGARDH G, TRAGARDH C: Production of W/O/W emulsions and S/O/W pectin microcapsules by microchannel emulsification. Colloid Stuface A (2001) 189:257–264.
  • Encyclopedia of Pharmaceutical Technology. SWARBRICK J, BOYLAN JC (Ed.) (2000):207–221.
  • BEUSELINCK L, GOVERS G, POESEN J et al.: Grain-size analysis by laser diffractometry: comparison with the sieve-pipette method. CATENA (1998) 32(3-4):193–208.
  • WASHINGTON C: Particle Size Analysis in Pharmaceutics and Other Industries: Theory and Practice. (1992) ELLIS HORWOOD.
  • WYNN EJW, HOUNSLOW MJ: Coincidence correction for electrical-zone (Coulter-counter) particle size analysers. Powder Technology (1997) 93(2):163–175.
  • Micromeritics. In: Physical Pharmacy. Lippincott, Williams & Baltimore (2004):423–452.
  • US Pharmacopeia National Formulary (1995):1822–1823.
  • GOFFIN MEYVIS ANALYTICAL & MEDICAL SYSTEMS: Workshop on Image Analysers from Malvern Instruments (2004).
  • HICKEY AJ: Methods of aerosol particle size characterization. In: Pharmaceutical Inhalation Aerosol Technology. Drugs and the pharmaceutical sciences. HICKEY AJ (Ed.). Marcel Dekker, New York (2004):345–385.
  • US Pharmacopeia National Formulary (1995):1760–1767.
  • CARLI F, GARBASSI F: Characterization of drug loading in crospovidone by X-ray photoelectron spectroscopy. J. Pharm. (1985) 74(9):963–967.
  • VOINOVICH D, MONEGHINI M, PERISSUTTI B et al.: Preparation in high-shear mixer of sustained-release pellets by melt pelletisation. Int. J. Pharm. (2000) 203(1-2):235–244.
  • WESTESEN K, BUNJES H, KOCH MHJ: Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release. J. Control. Release (1997) 48:223–236.
  • WESTESEN K, SIEKMANN B, KOCH MHJ: Investigations on the physical state of lipid nanoparticles by synchrotron radiation X-ray diffraction. Int. J. Pharm. (1993) 93(1-3):189–199.
  • ELDEM T, SPEISER P, ALTORFER H: Polymorphic behavior of sprayed lipid micropellets and its evaluation by differential scanning calorimetry and scanning electron microscopy. Pharm. Res. (1991) 8(2):178–184.
  • Micromeritics. In: Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Sciences. Lea and Febiger, London (1993):423–449.
  • Micromeritics. In: Physical Pharmacy. Lippincott, Williams & Baltimore (2004):30–36.
  • VITEZ IM, NEWMAN AW, DAVIDOVICH M et al.: The evolution of hot-stage microscopy to aid solid-state characterizations of pharmaceutical solids. Thermochimica Acta (1998) 324(1-2): 187–196.
  • KANEKO F, TASHIRO K, KOBAYASHI M: Polymorphic transformations during crystallization processes of fatty acids studied with FT-IR spectroscopy. J. Cryst. Growth (1999) 198-199\(Part 2): 1352–1359.
  • YAZAN Y, DEMIREL M, BUYUKKOROGLU B et al.: Solid lipid microparticle versus inclusion complex of piribedil. Proceedings of the European Conference on Drug Delivery and Pharmaceutical Technology. 10–12 May, 2004. Seville, Spain (2004).
  • JASPART S, BODSON C, BERTHOLET P et al.: Solid lipid microparticles for administration by inhalation: optimisation of manufacturing parameters. Proceedings of the European Conference on DrugDelivery and Pharmaceutical Technology. 10-12 May, Seville, Spain (2004).
  • JASPART S, KIRSCHVINK N, CHIAP P et al.: Solid lipid microparticles for administration by inhalation: optimisation of manufacturing parameters and preliminary tolerance study. Proceedings 12th Forum of Pharmaceutical Sciences. 6–7 Blankenberge, Belgium (2004).
  • BLANCO-PRIETO MJ, BESSEGHIR K, ORSOLINI P et al.: Importance of the test medium for the release kinetics of a somatostatin analogue from poly(-lactide-co-glycolide) microspheres. Int. J. Pharm. (1999) 184(2):243–250.
  • WOO BH, KOSTANSKI JW, GEBREKIDAN S et al.: Preparation, characterization and in vivo evaluation of 120-day poly(-lactide) leuprolide microspheres. J. Control. Release (2001) 75(3):307–315.
  • OLBRICH C, MULLER RH: Enzymatic degradation of SLN-effect of surfactant and surfactant mixtures. Int. j Pharm. (1999) 180(1):31–39.
  • OLBRICH C, KAYSER O, MULLER RH: Lipase degradation of Dynasan 114 and 116 solid lipid nanoparticles (SLN)-effect of surfactants, storage time and crystallinity. Int. J. Pharm. (2002) 237(1-2):119–128.

Websites

  • OCCHIO: Imaging solutions in powder analysis: Alpaga and Callisto. http://www. occhio. be/(2004)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.